Full Press Release Details
WASHINGTON, May 31, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at SLEEP 2022, to be held in Charlotte, North Carolina from June 4-8, 2022.
The following scientific posters will be presented:
Presenter: Dr. Sandra Paulina Smieszek, Head of Genetics
Poster Session Presentation Time: 5:15 PM – 7:15 PM ET
Title: "Enrichment of RAI1 genetic aberrations associated with sleep disturbances in SMS, in Autism Spectrum Disorder"
Title: "A 10-week observational research study in individuals with delayed sleep-wake phase disorder (DSWPD) symptoms"
Title: "A novel missense variant in Melanopsin associates with delayed sleep phenotype: whole-genome sequencing study"
For more information on SLEEP 2022, please refer to https://www.sleepmeeting.org/.
About Vanda Pharmaceuticals Inc.
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.